Global Newborn Metabolic Screening Market Growth (Status and Outlook) 2026-2032
The global Newborn Metabolic Screening market size is predicted to grow from US$ 850 million in 2025 to US$ 1422 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.
Newborn metabolic screening, also known as newborn screening or heel-stick testing, is a public health program aimed at identifying certain metabolic, genetic, and congenital disorders in newborns shortly after birth. The screening involves collecting a small blood sample, typically obtained by pricking the newborn's heel, and testing it for the presence of specific markers associated with these disorders. Early detection allows for prompt intervention and treatment, often preventing or minimizing the development of serious health issues.
Continuous expansion of newborn screening panels to include additional metabolic, genetic, and congenital disorders. Advances in genetic testing technologies may contribute to the identification of new conditions.
LPI (LP Information)' newest research report, the “Newborn Metabolic Screening Industry Forecast” looks at past sales and reviews total world Newborn Metabolic Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Newborn Metabolic Screening sales for 2026 through 2032. With Newborn Metabolic Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn Metabolic Screening industry.
This Insight Report provides a comprehensive analysis of the global Newborn Metabolic Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Newborn Metabolic Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Newborn Metabolic Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn Metabolic Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn Metabolic Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Newborn Metabolic Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Newborn metabolic screening, also known as newborn screening or heel-stick testing, is a public health program aimed at identifying certain metabolic, genetic, and congenital disorders in newborns shortly after birth. The screening involves collecting a small blood sample, typically obtained by pricking the newborn's heel, and testing it for the presence of specific markers associated with these disorders. Early detection allows for prompt intervention and treatment, often preventing or minimizing the development of serious health issues.
Continuous expansion of newborn screening panels to include additional metabolic, genetic, and congenital disorders. Advances in genetic testing technologies may contribute to the identification of new conditions.
LPI (LP Information)' newest research report, the “Newborn Metabolic Screening Industry Forecast” looks at past sales and reviews total world Newborn Metabolic Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Newborn Metabolic Screening sales for 2026 through 2032. With Newborn Metabolic Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn Metabolic Screening industry.
This Insight Report provides a comprehensive analysis of the global Newborn Metabolic Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Newborn Metabolic Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Newborn Metabolic Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn Metabolic Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn Metabolic Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Newborn Metabolic Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Test
- Urine Test
- Hospital
- Specialty Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PerkinElmer
- Bio-Rad Laboratories
- Trivitron Healthcare Private Limited
- BioMedomics, Inc.
- Luminex Corporation
- MP BIOMEDICALS
- Synergy Medical Systems LLP
- Agilent Technologies, Inc
- Thermo Fisher Scientific, Inc
- Zivak Technologies
- Covidien Plc
- AB Sciex LLC
- Waters Corp.
- Masimo Corp.
- Natus Medical Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newborn Metabolic Screening Market Size (2021-2032)
2.1.2 Newborn Metabolic Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Newborn Metabolic Screening by Country/Region (2021, 2025 & 2032)
2.2 Newborn Metabolic Screening Segment by Type
2.2.1 Blood Test
2.2.2 Urine Test
2.2.3 Newborn Metabolic Screening Market Size by Type
2.2.3.1 Newborn Metabolic Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
2.3 Newborn Metabolic Screening Segment by Application
2.3.1 Hospital
2.3.2 Specialty Clinic
2.3.3 Others
2.3.4 Newborn Metabolic Screening Market Size by Application
2.3.4.1 Newborn Metabolic Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
3 NEWBORN METABOLIC SCREENING MARKET SIZE BY PLAYER
3.1 Newborn Metabolic Screening Market Size Market Share by Player
3.1.1 Global Newborn Metabolic Screening Revenue by Player (2021-2026)
3.1.2 Global Newborn Metabolic Screening Revenue Market Share by Player (2021-2026)
3.2 Global Newborn Metabolic Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEWBORN METABOLIC SCREENING BY REGION
4.1 Newborn Metabolic Screening Market Size by Region (2021-2026)
4.2 Global Newborn Metabolic Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Newborn Metabolic Screening Market Size Growth (2021-2026)
4.4 APAC Newborn Metabolic Screening Market Size Growth (2021-2026)
4.5 Europe Newborn Metabolic Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Newborn Metabolic Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Newborn Metabolic Screening Market Size by Country (2021-2026)
5.2 Americas Newborn Metabolic Screening Market Size by Type (2021-2026)
5.3 Americas Newborn Metabolic Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newborn Metabolic Screening Market Size by Region (2021-2026)
6.2 APAC Newborn Metabolic Screening Market Size by Type (2021-2026)
6.3 APAC Newborn Metabolic Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Newborn Metabolic Screening Market Size by Country (2021-2026)
7.2 Europe Newborn Metabolic Screening Market Size by Type (2021-2026)
7.3 Europe Newborn Metabolic Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newborn Metabolic Screening by Region (2021-2026)
8.2 Middle East & Africa Newborn Metabolic Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Newborn Metabolic Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEWBORN METABOLIC SCREENING MARKET FORECAST
10.1 Global Newborn Metabolic Screening Forecast by Region (2027-2032)
10.1.1 Global Newborn Metabolic Screening Forecast by Region (2027-2032)
10.1.2 Americas Newborn Metabolic Screening Forecast
10.1.3 APAC Newborn Metabolic Screening Forecast
10.1.4 Europe Newborn Metabolic Screening Forecast
10.1.5 Middle East & Africa Newborn Metabolic Screening Forecast
10.2 Americas Newborn Metabolic Screening Forecast by Country (2027-2032)
10.2.1 United States Market Newborn Metabolic Screening Forecast
10.2.2 Canada Market Newborn Metabolic Screening Forecast
10.2.3 Mexico Market Newborn Metabolic Screening Forecast
10.2.4 Brazil Market Newborn Metabolic Screening Forecast
10.3 APAC Newborn Metabolic Screening Forecast by Region (2027-2032)
10.3.1 China Newborn Metabolic Screening Market Forecast
10.3.2 Japan Market Newborn Metabolic Screening Forecast
10.3.3 Korea Market Newborn Metabolic Screening Forecast
10.3.4 Southeast Asia Market Newborn Metabolic Screening Forecast
10.3.5 India Market Newborn Metabolic Screening Forecast
10.3.6 Australia Market Newborn Metabolic Screening Forecast
10.4 Europe Newborn Metabolic Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Newborn Metabolic Screening Forecast
10.4.2 France Market Newborn Metabolic Screening Forecast
10.4.3 UK Market Newborn Metabolic Screening Forecast
10.4.4 Italy Market Newborn Metabolic Screening Forecast
10.4.5 Russia Market Newborn Metabolic Screening Forecast
10.5 Middle East & Africa Newborn Metabolic Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Newborn Metabolic Screening Forecast
10.5.2 South Africa Market Newborn Metabolic Screening Forecast
10.5.3 Israel Market Newborn Metabolic Screening Forecast
10.5.4 Turkey Market Newborn Metabolic Screening Forecast
10.6 Global Newborn Metabolic Screening Forecast by Type (2027-2032)
10.7 Global Newborn Metabolic Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Newborn Metabolic Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 PerkinElmer
11.1.1 PerkinElmer Company Information
11.1.2 PerkinElmer Newborn Metabolic Screening Product Offered
11.1.3 PerkinElmer Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 PerkinElmer Main Business Overview
11.1.5 PerkinElmer Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Newborn Metabolic Screening Product Offered
11.2.3 Bio-Rad Laboratories Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 Trivitron Healthcare Private Limited
11.3.1 Trivitron Healthcare Private Limited Company Information
11.3.2 Trivitron Healthcare Private Limited Newborn Metabolic Screening Product Offered
11.3.3 Trivitron Healthcare Private Limited Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Trivitron Healthcare Private Limited Main Business Overview
11.3.5 Trivitron Healthcare Private Limited Latest Developments
11.4 BioMedomics, Inc.
11.4.1 BioMedomics, Inc. Company Information
11.4.2 BioMedomics, Inc. Newborn Metabolic Screening Product Offered
11.4.3 BioMedomics, Inc. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BioMedomics, Inc. Main Business Overview
11.4.5 BioMedomics, Inc. Latest Developments
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Information
11.5.2 Luminex Corporation Newborn Metabolic Screening Product Offered
11.5.3 Luminex Corporation Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Luminex Corporation Main Business Overview
11.5.5 Luminex Corporation Latest Developments
11.6 MP BIOMEDICALS
11.6.1 MP BIOMEDICALS Company Information
11.6.2 MP BIOMEDICALS Newborn Metabolic Screening Product Offered
11.6.3 MP BIOMEDICALS Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 MP BIOMEDICALS Main Business Overview
11.6.5 MP BIOMEDICALS Latest Developments
11.7 Synergy Medical Systems LLP
11.7.1 Synergy Medical Systems LLP Company Information
11.7.2 Synergy Medical Systems LLP Newborn Metabolic Screening Product Offered
11.7.3 Synergy Medical Systems LLP Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Synergy Medical Systems LLP Main Business Overview
11.7.5 Synergy Medical Systems LLP Latest Developments
11.8 Agilent Technologies, Inc
11.8.1 Agilent Technologies, Inc Company Information
11.8.2 Agilent Technologies, Inc Newborn Metabolic Screening Product Offered
11.8.3 Agilent Technologies, Inc Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Agilent Technologies, Inc Main Business Overview
11.8.5 Agilent Technologies, Inc Latest Developments
11.9 Thermo Fisher Scientific, Inc
11.9.1 Thermo Fisher Scientific, Inc Company Information
11.9.2 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Product Offered
11.9.3 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Thermo Fisher Scientific, Inc Main Business Overview
11.9.5 Thermo Fisher Scientific, Inc Latest Developments
11.10 Zivak Technologies
11.10.1 Zivak Technologies Company Information
11.10.2 Zivak Technologies Newborn Metabolic Screening Product Offered
11.10.3 Zivak Technologies Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zivak Technologies Main Business Overview
11.10.5 Zivak Technologies Latest Developments
11.11 Covidien Plc
11.11.1 Covidien Plc Company Information
11.11.2 Covidien Plc Newborn Metabolic Screening Product Offered
11.11.3 Covidien Plc Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Covidien Plc Main Business Overview
11.11.5 Covidien Plc Latest Developments
11.12 AB Sciex LLC
11.12.1 AB Sciex LLC Company Information
11.12.2 AB Sciex LLC Newborn Metabolic Screening Product Offered
11.12.3 AB Sciex LLC Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 AB Sciex LLC Main Business Overview
11.12.5 AB Sciex LLC Latest Developments
11.13 Waters Corp.
11.13.1 Waters Corp. Company Information
11.13.2 Waters Corp. Newborn Metabolic Screening Product Offered
11.13.3 Waters Corp. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Waters Corp. Main Business Overview
11.13.5 Waters Corp. Latest Developments
11.14 Masimo Corp.
11.14.1 Masimo Corp. Company Information
11.14.2 Masimo Corp. Newborn Metabolic Screening Product Offered
11.14.3 Masimo Corp. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Masimo Corp. Main Business Overview
11.14.5 Masimo Corp. Latest Developments
11.15 Natus Medical Inc.
11.15.1 Natus Medical Inc. Company Information
11.15.2 Natus Medical Inc. Newborn Metabolic Screening Product Offered
11.15.3 Natus Medical Inc. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Natus Medical Inc. Main Business Overview
11.15.5 Natus Medical Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newborn Metabolic Screening Market Size (2021-2032)
2.1.2 Newborn Metabolic Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Newborn Metabolic Screening by Country/Region (2021, 2025 & 2032)
2.2 Newborn Metabolic Screening Segment by Type
2.2.1 Blood Test
2.2.2 Urine Test
2.2.3 Newborn Metabolic Screening Market Size by Type
2.2.3.1 Newborn Metabolic Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
2.3 Newborn Metabolic Screening Segment by Application
2.3.1 Hospital
2.3.2 Specialty Clinic
2.3.3 Others
2.3.4 Newborn Metabolic Screening Market Size by Application
2.3.4.1 Newborn Metabolic Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
3 NEWBORN METABOLIC SCREENING MARKET SIZE BY PLAYER
3.1 Newborn Metabolic Screening Market Size Market Share by Player
3.1.1 Global Newborn Metabolic Screening Revenue by Player (2021-2026)
3.1.2 Global Newborn Metabolic Screening Revenue Market Share by Player (2021-2026)
3.2 Global Newborn Metabolic Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEWBORN METABOLIC SCREENING BY REGION
4.1 Newborn Metabolic Screening Market Size by Region (2021-2026)
4.2 Global Newborn Metabolic Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Newborn Metabolic Screening Market Size Growth (2021-2026)
4.4 APAC Newborn Metabolic Screening Market Size Growth (2021-2026)
4.5 Europe Newborn Metabolic Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Newborn Metabolic Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Newborn Metabolic Screening Market Size by Country (2021-2026)
5.2 Americas Newborn Metabolic Screening Market Size by Type (2021-2026)
5.3 Americas Newborn Metabolic Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newborn Metabolic Screening Market Size by Region (2021-2026)
6.2 APAC Newborn Metabolic Screening Market Size by Type (2021-2026)
6.3 APAC Newborn Metabolic Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Newborn Metabolic Screening Market Size by Country (2021-2026)
7.2 Europe Newborn Metabolic Screening Market Size by Type (2021-2026)
7.3 Europe Newborn Metabolic Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newborn Metabolic Screening by Region (2021-2026)
8.2 Middle East & Africa Newborn Metabolic Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Newborn Metabolic Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEWBORN METABOLIC SCREENING MARKET FORECAST
10.1 Global Newborn Metabolic Screening Forecast by Region (2027-2032)
10.1.1 Global Newborn Metabolic Screening Forecast by Region (2027-2032)
10.1.2 Americas Newborn Metabolic Screening Forecast
10.1.3 APAC Newborn Metabolic Screening Forecast
10.1.4 Europe Newborn Metabolic Screening Forecast
10.1.5 Middle East & Africa Newborn Metabolic Screening Forecast
10.2 Americas Newborn Metabolic Screening Forecast by Country (2027-2032)
10.2.1 United States Market Newborn Metabolic Screening Forecast
10.2.2 Canada Market Newborn Metabolic Screening Forecast
10.2.3 Mexico Market Newborn Metabolic Screening Forecast
10.2.4 Brazil Market Newborn Metabolic Screening Forecast
10.3 APAC Newborn Metabolic Screening Forecast by Region (2027-2032)
10.3.1 China Newborn Metabolic Screening Market Forecast
10.3.2 Japan Market Newborn Metabolic Screening Forecast
10.3.3 Korea Market Newborn Metabolic Screening Forecast
10.3.4 Southeast Asia Market Newborn Metabolic Screening Forecast
10.3.5 India Market Newborn Metabolic Screening Forecast
10.3.6 Australia Market Newborn Metabolic Screening Forecast
10.4 Europe Newborn Metabolic Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Newborn Metabolic Screening Forecast
10.4.2 France Market Newborn Metabolic Screening Forecast
10.4.3 UK Market Newborn Metabolic Screening Forecast
10.4.4 Italy Market Newborn Metabolic Screening Forecast
10.4.5 Russia Market Newborn Metabolic Screening Forecast
10.5 Middle East & Africa Newborn Metabolic Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Newborn Metabolic Screening Forecast
10.5.2 South Africa Market Newborn Metabolic Screening Forecast
10.5.3 Israel Market Newborn Metabolic Screening Forecast
10.5.4 Turkey Market Newborn Metabolic Screening Forecast
10.6 Global Newborn Metabolic Screening Forecast by Type (2027-2032)
10.7 Global Newborn Metabolic Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Newborn Metabolic Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 PerkinElmer
11.1.1 PerkinElmer Company Information
11.1.2 PerkinElmer Newborn Metabolic Screening Product Offered
11.1.3 PerkinElmer Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 PerkinElmer Main Business Overview
11.1.5 PerkinElmer Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Newborn Metabolic Screening Product Offered
11.2.3 Bio-Rad Laboratories Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 Trivitron Healthcare Private Limited
11.3.1 Trivitron Healthcare Private Limited Company Information
11.3.2 Trivitron Healthcare Private Limited Newborn Metabolic Screening Product Offered
11.3.3 Trivitron Healthcare Private Limited Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Trivitron Healthcare Private Limited Main Business Overview
11.3.5 Trivitron Healthcare Private Limited Latest Developments
11.4 BioMedomics, Inc.
11.4.1 BioMedomics, Inc. Company Information
11.4.2 BioMedomics, Inc. Newborn Metabolic Screening Product Offered
11.4.3 BioMedomics, Inc. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BioMedomics, Inc. Main Business Overview
11.4.5 BioMedomics, Inc. Latest Developments
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Information
11.5.2 Luminex Corporation Newborn Metabolic Screening Product Offered
11.5.3 Luminex Corporation Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Luminex Corporation Main Business Overview
11.5.5 Luminex Corporation Latest Developments
11.6 MP BIOMEDICALS
11.6.1 MP BIOMEDICALS Company Information
11.6.2 MP BIOMEDICALS Newborn Metabolic Screening Product Offered
11.6.3 MP BIOMEDICALS Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 MP BIOMEDICALS Main Business Overview
11.6.5 MP BIOMEDICALS Latest Developments
11.7 Synergy Medical Systems LLP
11.7.1 Synergy Medical Systems LLP Company Information
11.7.2 Synergy Medical Systems LLP Newborn Metabolic Screening Product Offered
11.7.3 Synergy Medical Systems LLP Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Synergy Medical Systems LLP Main Business Overview
11.7.5 Synergy Medical Systems LLP Latest Developments
11.8 Agilent Technologies, Inc
11.8.1 Agilent Technologies, Inc Company Information
11.8.2 Agilent Technologies, Inc Newborn Metabolic Screening Product Offered
11.8.3 Agilent Technologies, Inc Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Agilent Technologies, Inc Main Business Overview
11.8.5 Agilent Technologies, Inc Latest Developments
11.9 Thermo Fisher Scientific, Inc
11.9.1 Thermo Fisher Scientific, Inc Company Information
11.9.2 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Product Offered
11.9.3 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Thermo Fisher Scientific, Inc Main Business Overview
11.9.5 Thermo Fisher Scientific, Inc Latest Developments
11.10 Zivak Technologies
11.10.1 Zivak Technologies Company Information
11.10.2 Zivak Technologies Newborn Metabolic Screening Product Offered
11.10.3 Zivak Technologies Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zivak Technologies Main Business Overview
11.10.5 Zivak Technologies Latest Developments
11.11 Covidien Plc
11.11.1 Covidien Plc Company Information
11.11.2 Covidien Plc Newborn Metabolic Screening Product Offered
11.11.3 Covidien Plc Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Covidien Plc Main Business Overview
11.11.5 Covidien Plc Latest Developments
11.12 AB Sciex LLC
11.12.1 AB Sciex LLC Company Information
11.12.2 AB Sciex LLC Newborn Metabolic Screening Product Offered
11.12.3 AB Sciex LLC Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 AB Sciex LLC Main Business Overview
11.12.5 AB Sciex LLC Latest Developments
11.13 Waters Corp.
11.13.1 Waters Corp. Company Information
11.13.2 Waters Corp. Newborn Metabolic Screening Product Offered
11.13.3 Waters Corp. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Waters Corp. Main Business Overview
11.13.5 Waters Corp. Latest Developments
11.14 Masimo Corp.
11.14.1 Masimo Corp. Company Information
11.14.2 Masimo Corp. Newborn Metabolic Screening Product Offered
11.14.3 Masimo Corp. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Masimo Corp. Main Business Overview
11.14.5 Masimo Corp. Latest Developments
11.15 Natus Medical Inc.
11.15.1 Natus Medical Inc. Company Information
11.15.2 Natus Medical Inc. Newborn Metabolic Screening Product Offered
11.15.3 Natus Medical Inc. Newborn Metabolic Screening Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Natus Medical Inc. Main Business Overview
11.15.5 Natus Medical Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Newborn Metabolic Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Newborn Metabolic Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Test
Table 4. Major Players of Urine Test
Table 5. Newborn Metabolic Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Table 8. Newborn Metabolic Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Table 11. Global Newborn Metabolic Screening Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Newborn Metabolic Screening Revenue Market Share by Player (2021-2026)
Table 13. Newborn Metabolic Screening Key Players Head office and Products Offered
Table 14. Newborn Metabolic Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Newborn Metabolic Screening Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Table 19. Global Newborn Metabolic Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Newborn Metabolic Screening Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Newborn Metabolic Screening Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Newborn Metabolic Screening Market Size Market Share by Country (2021-2026)
Table 23. Americas Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Table 25. Americas Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Table 27. APAC Newborn Metabolic Screening Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Table 29. APAC Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Newborn Metabolic Screening Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Newborn Metabolic Screening Market Size Market Share by Country (2021-2026)
Table 33. Europe Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Newborn Metabolic Screening Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Newborn Metabolic Screening
Table 39. Key Market Challenges & Risks of Newborn Metabolic Screening
Table 40. Key Industry Trends of Newborn Metabolic Screening
Table 41. Global Newborn Metabolic Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Newborn Metabolic Screening Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Newborn Metabolic Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Newborn Metabolic Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. PerkinElmer Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 46. PerkinElmer Newborn Metabolic Screening Product Offered
Table 47. PerkinElmer Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. PerkinElmer Main Business
Table 49. PerkinElmer Latest Developments
Table 50. Bio-Rad Laboratories Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 51. Bio-Rad Laboratories Newborn Metabolic Screening Product Offered
Table 52. Bio-Rad Laboratories Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bio-Rad Laboratories Main Business
Table 54. Bio-Rad Laboratories Latest Developments
Table 55. Trivitron Healthcare Private Limited Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 56. Trivitron Healthcare Private Limited Newborn Metabolic Screening Product Offered
Table 57. Trivitron Healthcare Private Limited Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Trivitron Healthcare Private Limited Main Business
Table 59. Trivitron Healthcare Private Limited Latest Developments
Table 60. BioMedomics, Inc. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 61. BioMedomics, Inc. Newborn Metabolic Screening Product Offered
Table 62. BioMedomics, Inc. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. BioMedomics, Inc. Main Business
Table 64. BioMedomics, Inc. Latest Developments
Table 65. Luminex Corporation Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 66. Luminex Corporation Newborn Metabolic Screening Product Offered
Table 67. Luminex Corporation Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Luminex Corporation Main Business
Table 69. Luminex Corporation Latest Developments
Table 70. MP BIOMEDICALS Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 71. MP BIOMEDICALS Newborn Metabolic Screening Product Offered
Table 72. MP BIOMEDICALS Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. MP BIOMEDICALS Main Business
Table 74. MP BIOMEDICALS Latest Developments
Table 75. Synergy Medical Systems LLP Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 76. Synergy Medical Systems LLP Newborn Metabolic Screening Product Offered
Table 77. Synergy Medical Systems LLP Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Synergy Medical Systems LLP Main Business
Table 79. Synergy Medical Systems LLP Latest Developments
Table 80. Agilent Technologies, Inc Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 81. Agilent Technologies, Inc Newborn Metabolic Screening Product Offered
Table 82. Agilent Technologies, Inc Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Agilent Technologies, Inc Main Business
Table 84. Agilent Technologies, Inc Latest Developments
Table 85. Thermo Fisher Scientific, Inc Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 86. Thermo Fisher Scientific, Inc Newborn Metabolic Screening Product Offered
Table 87. Thermo Fisher Scientific, Inc Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Thermo Fisher Scientific, Inc Main Business
Table 89. Thermo Fisher Scientific, Inc Latest Developments
Table 90. Zivak Technologies Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 91. Zivak Technologies Newborn Metabolic Screening Product Offered
Table 92. Zivak Technologies Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Zivak Technologies Main Business
Table 94. Zivak Technologies Latest Developments
Table 95. Covidien Plc Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 96. Covidien Plc Newborn Metabolic Screening Product Offered
Table 97. Covidien Plc Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Covidien Plc Main Business
Table 99. Covidien Plc Latest Developments
Table 100. AB Sciex LLC Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 101. AB Sciex LLC Newborn Metabolic Screening Product Offered
Table 102. AB Sciex LLC Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. AB Sciex LLC Main Business
Table 104. AB Sciex LLC Latest Developments
Table 105. Waters Corp. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 106. Waters Corp. Newborn Metabolic Screening Product Offered
Table 107. Waters Corp. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Waters Corp. Main Business
Table 109. Waters Corp. Latest Developments
Table 110. Masimo Corp. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 111. Masimo Corp. Newborn Metabolic Screening Product Offered
Table 112. Masimo Corp. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Masimo Corp. Main Business
Table 114. Masimo Corp. Latest Developments
Table 115. Natus Medical Inc. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 116. Natus Medical Inc. Newborn Metabolic Screening Product Offered
Table 117. Natus Medical Inc. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Natus Medical Inc. Main Business
Table 119. Natus Medical Inc. Latest Developments
Table 1. Newborn Metabolic Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Newborn Metabolic Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Test
Table 4. Major Players of Urine Test
Table 5. Newborn Metabolic Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Table 8. Newborn Metabolic Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Table 11. Global Newborn Metabolic Screening Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Newborn Metabolic Screening Revenue Market Share by Player (2021-2026)
Table 13. Newborn Metabolic Screening Key Players Head office and Products Offered
Table 14. Newborn Metabolic Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Newborn Metabolic Screening Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Table 19. Global Newborn Metabolic Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Newborn Metabolic Screening Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Newborn Metabolic Screening Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Newborn Metabolic Screening Market Size Market Share by Country (2021-2026)
Table 23. Americas Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Table 25. Americas Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Table 27. APAC Newborn Metabolic Screening Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Table 29. APAC Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Newborn Metabolic Screening Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Newborn Metabolic Screening Market Size Market Share by Country (2021-2026)
Table 33. Europe Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Newborn Metabolic Screening Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Newborn Metabolic Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Newborn Metabolic Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Newborn Metabolic Screening
Table 39. Key Market Challenges & Risks of Newborn Metabolic Screening
Table 40. Key Industry Trends of Newborn Metabolic Screening
Table 41. Global Newborn Metabolic Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Newborn Metabolic Screening Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Newborn Metabolic Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Newborn Metabolic Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. PerkinElmer Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 46. PerkinElmer Newborn Metabolic Screening Product Offered
Table 47. PerkinElmer Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. PerkinElmer Main Business
Table 49. PerkinElmer Latest Developments
Table 50. Bio-Rad Laboratories Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 51. Bio-Rad Laboratories Newborn Metabolic Screening Product Offered
Table 52. Bio-Rad Laboratories Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bio-Rad Laboratories Main Business
Table 54. Bio-Rad Laboratories Latest Developments
Table 55. Trivitron Healthcare Private Limited Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 56. Trivitron Healthcare Private Limited Newborn Metabolic Screening Product Offered
Table 57. Trivitron Healthcare Private Limited Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Trivitron Healthcare Private Limited Main Business
Table 59. Trivitron Healthcare Private Limited Latest Developments
Table 60. BioMedomics, Inc. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 61. BioMedomics, Inc. Newborn Metabolic Screening Product Offered
Table 62. BioMedomics, Inc. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. BioMedomics, Inc. Main Business
Table 64. BioMedomics, Inc. Latest Developments
Table 65. Luminex Corporation Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 66. Luminex Corporation Newborn Metabolic Screening Product Offered
Table 67. Luminex Corporation Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Luminex Corporation Main Business
Table 69. Luminex Corporation Latest Developments
Table 70. MP BIOMEDICALS Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 71. MP BIOMEDICALS Newborn Metabolic Screening Product Offered
Table 72. MP BIOMEDICALS Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. MP BIOMEDICALS Main Business
Table 74. MP BIOMEDICALS Latest Developments
Table 75. Synergy Medical Systems LLP Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 76. Synergy Medical Systems LLP Newborn Metabolic Screening Product Offered
Table 77. Synergy Medical Systems LLP Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Synergy Medical Systems LLP Main Business
Table 79. Synergy Medical Systems LLP Latest Developments
Table 80. Agilent Technologies, Inc Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 81. Agilent Technologies, Inc Newborn Metabolic Screening Product Offered
Table 82. Agilent Technologies, Inc Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Agilent Technologies, Inc Main Business
Table 84. Agilent Technologies, Inc Latest Developments
Table 85. Thermo Fisher Scientific, Inc Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 86. Thermo Fisher Scientific, Inc Newborn Metabolic Screening Product Offered
Table 87. Thermo Fisher Scientific, Inc Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Thermo Fisher Scientific, Inc Main Business
Table 89. Thermo Fisher Scientific, Inc Latest Developments
Table 90. Zivak Technologies Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 91. Zivak Technologies Newborn Metabolic Screening Product Offered
Table 92. Zivak Technologies Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Zivak Technologies Main Business
Table 94. Zivak Technologies Latest Developments
Table 95. Covidien Plc Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 96. Covidien Plc Newborn Metabolic Screening Product Offered
Table 97. Covidien Plc Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Covidien Plc Main Business
Table 99. Covidien Plc Latest Developments
Table 100. AB Sciex LLC Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 101. AB Sciex LLC Newborn Metabolic Screening Product Offered
Table 102. AB Sciex LLC Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. AB Sciex LLC Main Business
Table 104. AB Sciex LLC Latest Developments
Table 105. Waters Corp. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 106. Waters Corp. Newborn Metabolic Screening Product Offered
Table 107. Waters Corp. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Waters Corp. Main Business
Table 109. Waters Corp. Latest Developments
Table 110. Masimo Corp. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 111. Masimo Corp. Newborn Metabolic Screening Product Offered
Table 112. Masimo Corp. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Masimo Corp. Main Business
Table 114. Masimo Corp. Latest Developments
Table 115. Natus Medical Inc. Details, Company Type, Newborn Metabolic Screening Area Served and Its Competitors
Table 116. Natus Medical Inc. Newborn Metabolic Screening Product Offered
Table 117. Natus Medical Inc. Newborn Metabolic Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Natus Medical Inc. Main Business
Table 119. Natus Medical Inc. Latest Developments
LIST OF FIGURES
Figure 1. Newborn Metabolic Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Newborn Metabolic Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Newborn Metabolic Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Newborn Metabolic Screening Sales Market Share by Country/Region (2025)
Figure 8. Newborn Metabolic Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Newborn Metabolic Screening Market Size Market Share by Type in 2025
Figure 10. Newborn Metabolic Screening in Hospital
Figure 11. Global Newborn Metabolic Screening Market: Hospital (2021-2026) & ($ millions)
Figure 12. Newborn Metabolic Screening in Specialty Clinic
Figure 13. Global Newborn Metabolic Screening Market: Specialty Clinic (2021-2026) & ($ millions)
Figure 14. Newborn Metabolic Screening in Others
Figure 15. Global Newborn Metabolic Screening Market: Others (2021-2026) & ($ millions)
Figure 16. Global Newborn Metabolic Screening Market Size Market Share by Application in 2025
Figure 17. Global Newborn Metabolic Screening Revenue Market Share by Player in 2025
Figure 18. Global Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Figure 19. Americas Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 20. APAC Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 21. Europe Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 23. Americas Newborn Metabolic Screening Value Market Share by Country in 2025
Figure 24. United States Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Newborn Metabolic Screening Market Size Market Share by Region in 2025
Figure 29. APAC Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Figure 30. APAC Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Figure 31. China Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. India Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Newborn Metabolic Screening Market Size Market Share by Country in 2025
Figure 38. Europe Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Figure 39. Europe Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Figure 40. Germany Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. France Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 54. APAC Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 55. Europe Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 57. United States Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 58. Canada Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 59. Mexico Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 60. Brazil Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 61. China Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 62. Japan Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 63. Korea Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 65. India Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 66. Australia Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 67. Germany Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 68. France Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 69. UK Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 70. Italy Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 71. Russia Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 72. Egypt Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 73. South Africa Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 74. Israel Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 75. Turkey Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 76. Global Newborn Metabolic Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Newborn Metabolic Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 1. Newborn Metabolic Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Newborn Metabolic Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Newborn Metabolic Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Newborn Metabolic Screening Sales Market Share by Country/Region (2025)
Figure 8. Newborn Metabolic Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Newborn Metabolic Screening Market Size Market Share by Type in 2025
Figure 10. Newborn Metabolic Screening in Hospital
Figure 11. Global Newborn Metabolic Screening Market: Hospital (2021-2026) & ($ millions)
Figure 12. Newborn Metabolic Screening in Specialty Clinic
Figure 13. Global Newborn Metabolic Screening Market: Specialty Clinic (2021-2026) & ($ millions)
Figure 14. Newborn Metabolic Screening in Others
Figure 15. Global Newborn Metabolic Screening Market: Others (2021-2026) & ($ millions)
Figure 16. Global Newborn Metabolic Screening Market Size Market Share by Application in 2025
Figure 17. Global Newborn Metabolic Screening Revenue Market Share by Player in 2025
Figure 18. Global Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Figure 19. Americas Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 20. APAC Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 21. Europe Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Newborn Metabolic Screening Market Size 2021-2026 ($ millions)
Figure 23. Americas Newborn Metabolic Screening Value Market Share by Country in 2025
Figure 24. United States Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Newborn Metabolic Screening Market Size Market Share by Region in 2025
Figure 29. APAC Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Figure 30. APAC Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Figure 31. China Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. India Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Newborn Metabolic Screening Market Size Market Share by Country in 2025
Figure 38. Europe Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Figure 39. Europe Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Figure 40. Germany Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. France Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Newborn Metabolic Screening Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Newborn Metabolic Screening Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Newborn Metabolic Screening Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Newborn Metabolic Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 54. APAC Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 55. Europe Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 57. United States Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 58. Canada Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 59. Mexico Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 60. Brazil Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 61. China Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 62. Japan Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 63. Korea Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 65. India Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 66. Australia Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 67. Germany Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 68. France Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 69. UK Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 70. Italy Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 71. Russia Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 72. Egypt Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 73. South Africa Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 74. Israel Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 75. Turkey Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
Figure 76. Global Newborn Metabolic Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Newborn Metabolic Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Newborn Metabolic Screening Market Size 2027-2032 ($ millions)
